e-learning
resources
Virtual 2020
Pre-Congress Content
Air pollution and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Red Blood Cell Distribution Width as a potential predictor of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
S. Rodrigues Sousa (Coimbra, Portugal), J. Nunes Caldeira (Coimbra, Portugal), C. Rodrigues (Coimbra, Portugal), A. Figueiredo (Coimbra, Portugal), F. Barata (Coimbra, Portugal)
Source:
Virtual Congress 2020 – Air pollution and comorbidities
Session:
Air pollution and comorbidities
Session type:
E-poster session
Number:
131
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Rodrigues Sousa (Coimbra, Portugal), J. Nunes Caldeira (Coimbra, Portugal), C. Rodrigues (Coimbra, Portugal), A. Figueiredo (Coimbra, Portugal), F. Barata (Coimbra, Portugal). Red Blood Cell Distribution Width as a potential predictor of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease. 131
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease
Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today
Year: 2019
A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 - Pre-reading material
Year: 2020
Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease
Source: Guideline 2014
Year: 2014
Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease
Source: Guideline 1999
Year: 1999
Patterns of Oxygen Pulse Response to Incremental Exercise in Patients with Chronic Obstructive Pulmonary Disease – An Observational Study
Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases
Year: 2017
Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Low Level of Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Distribution of body water in hospitalized patients with Chronic Obstructive Pulmonary Disease and Right Heart Failure.
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019
Nutritional Supplementation during Pulmonary Rehabilitation in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review
Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases
Year: 2019
Study Of Risk Factors For Arrhythmias Among Chronic Obstructive Pulmonary Disease Patients Having Ischaemic Heart Disease.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020
The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017
Chronic Obstructive Pulmonary Disease: A Forgotten Killer
Source: Eur Respir J 2009; 33: 456
Year: 2009
Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021
The Use of Respiratory Sounds for Automated Detection of Obstructive Pulmonary Disease: Do Lung Sound Labels Provide Value?
Source: International Congress 2017 – Lung function testing in different patient categories
Year: 2017
Cardiac Involvement In Chronic Obstructive Pulmonary Disease (COPD) Secondary To Post TB Bronchiectasis V/S Non Post Tb Bronchiectasis
Source: International Congress 2019 – Bronchiectasis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept